title: Treating dyslipidemia in patients with type 2 diabetes mellitus.
abstract: Type 2 diabetes mellitus is associated with significant cardiovascular morbidity and mortality. Diabetic dyslipidemia is a major cause of cardiovascular complications and a key area for intervention. The blood cholesterol treatment guideline released in 2013 and strategies to reduce cardiovascular risk are outlined and addressed in this article.
authors.affiliation: Michelle L. Frank is a family nurse practitioner student at University of Mary, Bismarck, N.D. Annie M. Gerhardt is adjunct faculty at the University of Mary, Bismarck, N.D. and a family nurse practitioner at Altru Clinic Lake Region, Devils Lake, N.D.
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Frank
authors.forename: Annie M
authors.initials: AM
authors.lastname: Gerhardt
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000188:drug therapy / Q000451:nursing* / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors